CareDx (CDNA) Tops Q2 EPS by 21c

CareDx (NASDAQ: CDNA) reported Q2 EPS of ($0.13), $0.21 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $80.6 million versus the consensus estimate of $81.85 million.

GUIDANCE:

CareDx sees FY2022 revenue of $325-335 million, versus the consensus of $338 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• H&R Block (HRB) Tops Q4 EPS by 7c, Offers Guidance
• Snail, Inc. (SNAL) Reports Q3 Loss of $0.36
• Sanara MedTech Inc. (SMTI) Misses Q2 EPS by 2c